The Nordic EMBL Partnership Coordination and Operations team assembled in Oslo for two days to advance joint initiatives.
Are you impressed when NASA manages to calculate the time and speed of a rocket’s trajectory? A new study shows that your brain has a “nerd centre” capable of even more complex calculations.
Ieva Rauluševičiūtė is a Doctoral Research Fellow in the Mathelier group at NCMM. She recently spent one month with the groups of Dr Judith Zaugg and Dr Arnaud Krebs at the EMBL Headquarters in Heidelberg, Germany.
NCMM is delighted to announce that Dr Charlotte Boccara has been recruited as a new group leader under the Centre’s precision medicine umbrella. Dr Boccara will join us in April 2022 . She will establish and head the Systems Neuroscience & Sleep group at NCMM, aiming to decode sleep function in healthy development.
In this article, we meet NCMM Group Leader and Zebrafish Core Facility Leader, Camila Esguerra, and learn about the power of zebrafish as a model organism and the core facility she directs at the University of Oslo.
NCMM is delighted to announce that Dr Biswajyoti Sahu has been recruited as a new group leader for Precision Medicine. Dr Sahu will join us in September 2022 from the University of Helsinki, Finland.
NCMM Group Leader Sebastian Waszak and his team are advancing the understanding of childhood brain tumor evolution, exploring new approaches to molecular diagnostics, and utilizing knowledge gained from clinical cancer genomics.
Anne Martina Kraus and Sophie Mottl are combining their clinical training with computational methods to understand the genetics of childhood brain tumors
NCMM group leader Dr Emma Haapaniemi, Professor Eivind Valen and collaborators will advance gene therapy for primary immunodeficiencies
The Norwegian research environment stands to benefit from the launch of the new European Molecular Biology Laboratory programme ‘Molecules to Ecosystems’
Joint seed funding from NCMM and UiT has been awarded to four projects investigating lung cancer treatment, pathogenic bacterial cells, breast cancer metastasis and kidney inflammation progression.
Torfinn is starting on the 1st of February 2022 and will be joining NCMM’s IT team. He will be working with NCMM’s computer servers.
NCMM group leader, Dr. Irep Gözen, and collaborators have been awarded the large, interdisciplinary research project grant from the Research Council of Norway and the University of Oslo